The Chan Zuckerberg Initiative (CZI) has launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in biology.  

To achieve this, CZI will collaborate with partners 10x Genomics, Ultima Genomics, and a group of leading researchers. 

Once completed, CZI hopes this single-cell data set will bring new data and resolution to multiple domains of biology that need comprehensive resources such as mapping genetic perturbations across diverse cell types and tissues.  

“CZI’s Billion Cells Project illustrates the power of collaboration to make previously unfathomable amounts of single-cell data available for researchers, which will help clarify our understanding of the fundamental biology underpinning human health and disease while supercharging efforts at the intersection of AI and biology,” said Jonah Cool, Cell Science Senior Science Program Officer at CZI.  

“Biology not only needs more data – the field needs more data faster and in interoperable formats to support AI models that address specific problems, and this project represents a unique approach to scaling and standardising scientific outputs for AI and more.” 

A roadmap for drug development

CZI has built one of the largest computing systems dedicated to nonprofit life sciences research in the world. Data generated from the Billion Cells Project will be used to train new virtual cell models using CZI’s computing system to derive greater insight into the vast dataset.  

CZI plans to make the results from this initiative open source and freely available to help scientists around the world make new discoveries about human biology. 

The partnership prioritises data generation across diverse biological domains, with initial data sets including organisms such as mouse, zebrafish, and primary human cell models. 

“This project will provide a necessary scale of data to understand the functional effects of human genetic variants and characterise the genetic drivers of human disease,” said Alexander Marson, Director of the Gladstone-UCSF Institute of Genomic Immunology and collaborator. “Ultimately, the Billion Cells Project will also be a functional roadmap to guide drug development, identifying targets to restore diseased cells to health.” 

The collaboration will use 10x Genomics’ Chromium GEM-X technology for single-cell analysis, while sequencing will be performed on the UG 100, an ultra-high throughput next-generation sequencing (NGS) platform developed by Ultima Genomics.

Diana Spencer, Senior Digital Content Editor, DDW